Gene expression profiling in whole blood of patients with coronary artery disease

Owing to the dynamic nature of the transcriptome, gene expression profiling is a promising tool for discovery of disease-related genes and biological pathways. In the present study, we examined gene expression in whole blood of 12 patients with CAD (coronary artery disease) and 12 healthy control subjects. Furthermore, ten patients with CAD underwent whole-blood gene expression analysis before and after the completion of a cardiac rehabilitation programme following surgical coronary revascularization. mRNA and miRNA (microRNA) were isolated for expression profiling. Gene expression analysis identified 365 differentially expressed genes in patients with CAD compared with healthy controls (175 up- and 190 down-regulated in CAD), and 645 in CAD rehabilitation patients (196 up- and 449 down-regulated post-rehabilitation). Biological pathway analysis identified a number of canonical pathways, including oxidative phosphorylation and mitochondrial function, as being significantly and consistently modulated across the groups. Analysis of miRNA expression revealed a number of differentially expressed miRNAs, including hsa-miR-140-3p (control compared with CAD, P=0.017), hsa-miR-182 (control compared with CAD, P=0.093), hsa-miR-92a and hsa-miR-92b (post- compared with pre-exercise, P<0.01). Global analysis of predicted miRNA targets found significantly reduced expression of genes with target regions compared with those without: hsa-miR-140-3p (P=0.002), hsa-miR-182 (P=0.001), hsa-miR-92a and hsa-miR-92b (P=2.2×10−16). In conclusion, using whole blood as a ‘surrogate tissue’ in patients with CAD, we have identified differentially expressed miRNAs, differentially regulated genes and modulated pathways which warrant further investigation in the setting of cardiovascular function. This approach may represent a novel non-invasive strategy to unravel potentially modifiable pathways and possible therapeutic targets in cardiovascular disease.

[1]  Karl T Kelsey,et al.  MicroRNA responses to cellular stress. , 2006, Cancer research.

[2]  A. Zaas,et al.  Peripheral blood gene expression profiling for cardiovascular disease assessment , 2007, Genomic Medicine.

[3]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[4]  D. Harrison,et al.  Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[5]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[6]  Cheng Cheng,et al.  Sample size determination for the false discovery rate , 2005, Bioinform..

[7]  B. Aronow,et al.  Microarray Analysis of Focal Segmental Glomerulosclerosis , 2004, American Journal of Nephrology.

[8]  K. Anastasiadis,et al.  Diabetes mellitus and coronary revascularization procedures. , 2007, International journal of cardiology.

[9]  W. Sui,et al.  Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. , 2008, Transplant immunology.

[10]  A. Dominiczak,et al.  Mitochondria-Targeted Antioxidant MitoQ10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy , 2009, Hypertension.

[11]  Ian B. Jeffery,et al.  Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data , 2006, BMC Bioinformatics.

[12]  Yurong Fu,et al.  Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues , 2010, Journal of Cancer Research and Clinical Oncology.

[13]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[14]  RAINER BREITLING,et al.  Rank-based Methods as a Non-parametric Alternative of the T-statistic for the Analysis of Biological Microarray Data , 2005, J. Bioinform. Comput. Biol..

[15]  A. Dominiczak,et al.  Low-Density Lipoprotein Cholesterol Determines Oxidative Stress and Endothelial Dysfunction in Saphenous Veins From Patients With Coronary Artery Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[17]  Thomas Thum,et al.  MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.

[18]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[19]  David A Stenger,et al.  Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. , 2003, Journal of immunological methods.

[20]  Hong Zhong,et al.  Novel Blood Biomarkers of Human Urinary Bladder Cancer , 2006, Clinical Cancer Research.

[21]  G. Zalba,et al.  Oxidative Stress, Endothelial Dysfunction and Cerebrovascular Disease , 2007, Cerebrovascular Diseases.

[22]  A. Dominiczak,et al.  Vascular stiffness is related to superoxide generation in the vessel wall , 2008, Journal of hypertension.

[23]  P. Pagano,et al.  Targeting reactive oxygen species in hypertension , 2006, Current opinion in nephrology and hypertension.

[24]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[25]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[26]  V. Víctor,et al.  Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. , 2009, Current medicinal chemistry.

[27]  Thomas Thum,et al.  MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007 .

[28]  Reliability, Validity, and Responsiveness of the Six-minute Walk Test in Patients with Heart Failure. , 2002 .

[29]  Y. Lee,et al.  Journal of Clinical Laboratory Analysis 19:182–188 (2005) Optimization of the PAXgene TM Blood RNA Extraction System for Gene Expression Analysis of Clinical Samples , 2022 .

[30]  K. Abromeit Music Received , 2023, Notes.

[31]  Pascal J. Goldschmidt-Clermont,et al.  Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease , 2009, PloS one.

[32]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[33]  Jun Ma,et al.  The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. , 2006, The Journal of laboratory and clinical medicine.

[34]  G. Marchant Toxicogenomics and toxic torts. , 2002, Trends in biotechnology.

[35]  Jason Laramie,et al.  Whole blood and leukocyte RNA isolation for gene expression analyses. , 2004, Physiological genomics.

[36]  R V Jensen,et al.  Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[38]  Danish Sayed,et al.  MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007 .

[39]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[40]  M. Fournier,et al.  High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[42]  Walter Kolch,et al.  Urinary Proteomic Biomarkers in Coronary Artery Disease*S , 2008, Molecular & Cellular Proteomics.

[43]  Uwe Oelmueller,et al.  Stabilization of mRNA expression in whole blood samples. , 2002, Clinical chemistry.

[44]  Rhian M. Touyz,et al.  NADPH Oxidases, Reactive Oxygen Species, and Hypertension , 2008, Diabetes Care.

[45]  D. Covell,et al.  Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data. , 2003, Molecular cancer therapeutics.

[46]  B. Xiao,et al.  Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues , 2009, Journal of gastroenterology and hepatology.

[47]  S. Moncada,et al.  AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. , 2009, The Biochemical journal.

[48]  R. Russell,et al.  bantam Encodes a Developmentally Regulated microRNA that Controls Cell Proliferation and Regulates the Proapoptotic Gene hid in Drosophila , 2003, Cell.